| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |